
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
Case History: 28-year-old male presents with history of headaches.
Case History: 28-year-old male presents with history of headaches.
